Monitoring post-approval drug safety in pregnancy: pharmacogenetic aspects
The purpose of this article is to describe and to examine the utility of new pharmacogenetic approaches in monitoring post-approval drug safety in pregnancy. Data on gene expression in pregnancy and metabolic variation may, in specific instances, help to predict adverse drug reactions in the mother-...
Guardat en:
| Format: | Artigo |
|---|---|
| Idioma: | Russo |
| Publicat: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
| Col·lecció: | Безопасность и риск фармакотерапии |
| Matèries: | |
| Accés en línia: | https://www.risksafety.ru/jour/article/view/19 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|